 |
 |
General Industry
|
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
| Title |
|
Chapter 2: Pharmaceutical Market Issues |
|
| Sub title |
|
|
|
| Author |
|
- |
|
| Publication date |
|
May 2005 |
|
| ISBN |
|
|
|
| Pages |
|
Information currently unavailable |
|
| Price |
|
pdf £68 | print n/a |
 |
 |
Summary
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 TABLE OF CONTENTS |
 |
The importance of the Latin American pharmaceutical market
Case study: Celebrex makes strong sales debut in Latin America
Case study: Sanofi-Aventis strengthens position in Latin American OTC market
Pharmaceutical R&D in Latin America
Case study: Brazil sets up major vaccine manufacturing plant
GlaxoSmithKline selects Mexico to launch new rotavirus vaccine
Case study: La Federación Latinoamericana de la Industria Farmacéutica
Intellectual property issues
Intellectual property protection in Latin America
Changes in the environment for intellectual property in Latin America
Weaknesses of Latin American intellectual property protection
Article 39-3 of the Agreement on Trade-related Aspects of Intellectual Property Rights
|
|
|
|
General Industry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
| No additional author information available for this product |
|
|
|
|
|
